In pulmonary arterial hypertension, higher TBR in the right ventricle and pulmonary arteries is linked to worse clinical outcomes over a median follow-up of 17 months.
Does 18F-FAPI PET/CT imaging predict clinical worsening events in patients with pulmonary arterial hypertension?
18F-FAPI PET/CT imaging demonstrates prognostic value in pulmonary arterial hypertension, with higher right ventricular and pulmonary artery uptake associated with clinical worsening.
Absolute Event Rate: 0% vs 0%
BACKGROUND: Emerging evidence demonstrates increased fluorine-18-fibroblast activation protein inhibitor ( OBJECTIVES: This study evaluated the prognostic value of METHODS: Forty-six consecutive PAH patients underwent RESULTS: Over a median follow-up period of 17.0 months, 22 patients (47.8%) experienced clinical worsening events. The TBR in the RV and PAs progressively increased with higher risk strata (all P < 0.05). Significantly higher TBR in the RV and PAs were observed in clinical worsening vs non-clinical worsening patients (all P < 0.05). Multivariable Cox regression analysis identified the TBR of RV free wall (TBR
Chen et al. (Thu,) reported a other. In pulmonary arterial hypertension, higher TBR in the right ventricle and pulmonary arteries is linked to worse clinical outcomes over a median follow-up of 17 months.